您要查找的是不是:
- EPL is a safe and effective drug in the treatment of chronic liver diseases. 易善力注射液治疗慢性肝病疗效确切且安全可靠。
- AIM To study the antifibrotic effect of calcium channel blockers)CCB)on chronic liver diseases. 目的:研究钙通道阻滞刑(CCB)抗肝纤维化的作用。
- Clinical study on the influential factors in the treatment of chronic liver diseases related gastro-duodenal ulcer. 影响肝源性胃十二指肠溃疡愈合的因素研究。
- The content of serum HA and SCG is determined by RIA in 150 patients of chronic liver diseases. 采用RIA法对150例肝病患者进行血清HA(透明质酸)和SCG(甘胆酸)含量的测定。
- It was important to detect the ICDH and CHE for judging the degree of chronic liver diseases and tr eating effect. 检测ICDH、CHE的变化可以反映肝病发展的程度,对判定治疗效果及预后有重要意义。
- Abstract: The content of serum HA and SCG is determined by RIA in 150 patients of chronic liver diseases. 采用RIA法对150例肝病患者进行血清HA(透明质酸)和SCG(甘胆酸)含量的测定。
- Measuring the level of serum lepin in chronic liver disease. 慢性肝病血清瘦素水平测定。
- HGV infection was common in the liver tissues of patients with chronic liver diseases. 在慢性肝病患者肝组织中HGV感染较为常见。
- Neuropsychiatric symptoms occuring in patients with acute or chronic liver diseases. 严重肝脏疾病引起的神经精神综合征.
- Liver fibrosis is the excessive accumulation of extracellular matrix (ECM) proteins that occurs in most types of chronic liver diseases. 肝纤维化是指由多种慢性疾病引起的肝脏持续的创伤修复反应而导致的细胞外基质(ECM)过度沉积和肝脏功能的受损。
- TTV DNA was frequent in the patients with non-A to C acute liver diseases and non B to C chronic liver diseases in Changchun area. TTV -DNA在非甲非乙非丙型急性及非乙非丙型慢性肝炎中的感染率最高 ;
- It suggests that the test of serum HA and SCG and their combined test are the ideal targets for discriminating and diagnosing chronic liver diseases. 提示对血清进行HA和SCG检测及其与常规肝功联合检测是目前对慢性肝病鉴别诊断的理想指标。
- Hepatic fibrosis is the common pathological feature of chronic liver diseases, which belongs to "mass in the abdomen", "hypochondriac pain" in TCM. 肝纤维化是慢性肝病的共同病理特征,属于中医"症积"、"胁痛"等范畴。
- Lastly, the workers with susceptible XRCC1 gene and HBs-Ag and/or anti-HCV infection had greater risk for chronic liver diseases. 同时,具有XRCC1易感性基因型并有B型或C型肝炎病毒感染的工人更为容易发生慢性肝疾病。
- Methods Examining ICDH and CHE in sera of 70 aged patient s with chronic liver diseases and 54 normal cases as a control. 方法对70例老年慢性肝病患者及54例健康老人血清中ICDH和CHE活性进行检测。
- Hepatology Digest: Cholestatic liver disease is a rare chronic liver disease. 国际肝病: 胆汁淤积性肝病是一种罕见的慢性肝病。
- Results The activities of ICDH and CHE in sera of aged pa tients with chronic liver diseases were much lower and higher respectively than those of control group (P<0.01). 结果老年慢性肝病患者血清中CHE活性明显低于正常对照组,且随病情加重降低更为明显(P<0.;01);
- This paper summarize the study of the relationgships between Helicobacter pylori infection and chronic liver diseases,liver encephalopathy and liver cacer. 本文对幽门螺杆菌感染与慢性肝病、肝性脑病及肝癌等肝脏疾病的关系进行了综述。
- Objective To expflore the changes and clinical significan ce of isocitrate dehydrogenase(ICDH) and cholinesterase(CHE) in sera of aged pat ients with chronic liver diseases. 目的探讨老年慢性肝病患者血清异柠檬酸脱氢酶(ICDH)和胆碱脂酶(CHE)的变化及临床意义。
- Background: Impaired local immune defense and microenvironment of gastrointestinal tract in patients with chronic liver diseases are in favor of bacteria overgrowth. 摘要背景:慢性肝病时胃肠道局部的免疫防御机制受损,肠道的微环境遭到破坏,有利于细菌的生长。